Type 2 Diabetes Archives - Page 103 of 145 - Endocrinology Advisor

Type 2 Diabetes

FDA Approves Lucentis for Diabetic Retinopathy With Diabetic Macular Edema

Synjardy XR Earns FDA Approval

The Food and Drug Administration (FDA) has approved Synjardy XR (empagliflozin and metformin HCl extended-release; Boehringer Ingelheim and Lilly) tablets as an adjunct to diet and exercise to improve blood sugar in adults with type 2 diabetes when both empagliflozin and metformin can be taken.

Young child with diabetes

Tresiba Approved for Pediatric Patients With Diabetes

The US Food and Drug Administration (FDA) has approved an expanded indication for Tresiba┬« (insulin degludec injection 100 U/mL, 200 U/mL) for use in children and adolescents with diabetes, Novo Nordisk announced in a press release. Tresiba, a once-daily, long-acting basal insulin, is now indicated to improve glycemic control in patients aged 1 year and…

Next post in Type 2 Diabetes